相关实验视频

Updated: Jun 20, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

用IVT-mRNA重新编程髓状细胞,用于癌症免疫疗法

Kevon J Jolly¹, Fan Zhang²

¹Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, United States.

Advances in pharmacology (San Diego, Calif.)

|July 21, 2024

概括

在体外转录的信使RNAs (IVT-mRNAs) 显示出重新编程髓状细胞治疗癌症和免疫疾病的前景. 这种方法利用mRNA技术用于针对复杂疾病的新型治疗策略.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
治疗方法治疗方法

背景情况:

使者RNA (mRNA) 疗法,包括体外转录的使者RNA (IVT-mRNA),在COVID-19 mRNA疫苗的成功之后获得了显著的引力.
目前正在探索IVT-mRNA用于疫苗之外的各种治疗应用,例如蛋白质替代,基因编辑和细胞重编程.
骨髓状细胞是参与疾病进展和免疫调节的重要免疫成分,使它们成为治疗干预的关键目标.

研究的目的:

审查使用IVT-mRNAs编程髓状细胞治疗癌症和免疫相关疾病的进展.
讨论IVT-mRNAs的药理学,髓状细胞的生物学,以及当前的髓状细胞向治疗方法.
介绍和分析现有的IVT-mRNA基于骨髓细胞重编程的策略,包括它们的优点和局限性.

主要方法:

对IVT-mRNA药理学和骨髓细胞生物学当前文献的综述.
对现有的基于IVT-mRNA的治疗方法进行分析,以向髓状细胞.
讨论这些新型治疗策略的优点和局限性.

主要成果:

IVT-mRNAs为编程髓状细胞提供了一个多功能平台,在癌症免疫疗法和治疗免疫相关疾病方面具有潜力.
目前的策略表明,使用IVT-mRNAs向和重编程髓状细胞的可行性.
了解IVT-mRNAs的药理学和髓状细胞的生物学对于成功的治疗设计至关重要.

结论:

通过重编程髓状细胞,IVT-mRNA技术对开发新型免疫疗法具有显著的前景.
需要进一步的研究和仔细的设计考虑,以优化基于mRNA的方法来向髓状细胞.
这种治疗方向代表了癌症免疫疗法和免疫疾病治疗的快速发展的前沿.

关键词:

抗体是对抗体的一种.癌症免疫疗法癌症免疫疗法细胞重编程可以进行.细胞疗法是一种细胞疗法.树突性细胞树突性细胞基因编辑基因编辑这就是IVT-mRNA.巨细胞是一个巨细胞.单细胞 (Monocytes) 是一种单细胞.疫苗疫苗疫苗疫苗

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...